pVITRO-HPV11 L1L2 Citations (1)
Originally described in: Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.Kwak K, Jiang R, Wang JW, Jagu S, Kirnbauer R, Roden RB PLoS One. 2014 May 9;9(5):e97232. doi: 10.1371/journal.pone.0097232. eCollection 2014. PubMed Journal
Articles Citing pVITRO-HPV11 L1L2
| Articles |
|---|
| WTAP-mediated m6A modification of IFNE is required for antiviral defense in condyloma acuminata. Gu Z, Liu J, Qin L, Zhang Y, Cui W, Huang H, Liu L, Cao Y, Zhang H. J Dermatol Sci. 2023 Aug;111(2):43-51. doi: 10.1016/j.jdermsci.2023.07.004. Epub 2023 Jul 20. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.